• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于[具体研究对象未给出]的微生物学研究,特别提及多重耐药性。

A Microbiological Study of with Special Reference to Multidrug Resistance.

作者信息

Longjam Langamba Angom, Tsering Dechen Chomu, Das Dipmala

机构信息

Department of Microbiology, Sikkim Manipal Institute of Medical Sciences, Gangtok, Sikkim, India.

Department of Microbiology, IQ City Medical College and Hospital, Durgapur, West Bengal, India.

出版信息

J Lab Physicians. 2021 Sep 22;14(2):169-174. doi: 10.1055/s-0041-1735583. eCollection 2022 Jun.

DOI:10.1055/s-0041-1735583
PMID:35982877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9381315/
Abstract

The outbreak of ( ) is mainly reported to be a notorious pathogens at health-care settings. It is the major problem on the health-care system with high morbidity and mortality rates because of the broad range of antibiotic resistance and lack of understanding the mechanism of developing new antibiotic resistance rapidly. It emphasizes the importance of local surveillance in describing or understanding and predicting microbial resistance patterns so that there will be limited use of antibiotics by developing strategies to control the extensive use of antimicrobial chemotherapy in clinical environment, which is still considered as one of the factors in the emergence of multidrug resistance microorganisms.  The study aims to detect the occurrence rate of infections from various clinical samples, identify the resistance levels to different groups of antimicrobial agents, and the occurrence rate of multidrug resistant (MDR) clinical isolates from a tertiary hospital in Durgapur, West Bengal, India.  The study was performed in the Department of Microbiology of the IQ City Medical College and Hospital, Durgapur, West Bengal, India, for the 24 months duration, that is, from January 1, 2018 to December 31, 2019. Altogether 15,800 clinical samples consisting of endotracheal tube aspirates, sputum, pus, blood, catheter tips, urine, tissue, and other body fluids were studied. from clinical samples were identified by its characteristic colonies (nonlactose fermenting, glistening, small mucoid colonies), Gram-staining pattern (Gram-negative coccobacillus), and standard biochemical reactions. It was further confirmed in the Department of Microbiology of the Healthworld Hospital, Durgapur, West Bengal, India, by Vitek2 compact system (bioMerieux, Inc., Durham, North Carolina, United States). Antibiotic susceptibility testing was performed using automated broth microdilutions by Vitek2 compact system (bioMerieux, Inc.) and Kirby-Bauer disk diffusion test on Mueller-Hinton Agar (HiMedia).  Nonrepetitive 289 were isolated from various clinical samples. A total of 277 (96%) isolates of were MDR strains.   was mostly isolated from the intensive care unit department and was found to be the most MDR type in the tertiary care hospital by this study.

摘要

( )的爆发主要被报道为医疗机构中一种臭名昭著的病原体。由于其广泛的抗生素耐药性以及对迅速产生新的抗生素耐药性机制缺乏了解,它是医疗系统面临的主要问题,发病率和死亡率都很高。这凸显了当地监测在描述、理解和预测微生物耐药模式方面的重要性,以便通过制定策略来控制临床环境中抗菌化疗的广泛使用,从而限制抗生素的使用,而临床环境中抗菌化疗的广泛使用仍被认为是多重耐药微生物出现的因素之一。本研究旨在检测印度西孟加拉邦杜尔加布尔一家三级医院各类临床样本中( )感染的发生率,确定对不同组抗菌药物的耐药水平,以及多重耐药(MDR)( )临床分离株的发生率。本研究在印度西孟加拉邦杜尔加布尔IQ市医学院和医院的微生物学系进行,为期24个月,即从2018年1月1日至2019年12月31日。共研究了15800份临床样本,包括气管内吸出物、痰液、脓液、血液、导管尖端、尿液、组织和其他体液。通过其特征性菌落(非乳糖发酵、有光泽、小黏液样菌落)、革兰氏染色模式(革兰氏阴性球杆菌)和标准生化反应从临床样本中鉴定出( )。在印度西孟加拉邦杜尔加布尔的Healthworld医院微生物学系通过Vitek2 compact系统(美国北卡罗来纳州达勒姆的bioMerieux公司)进一步确认。使用Vitek2 compact系统(bioMerieux公司)通过自动肉汤微量稀释法以及在穆勒-欣顿琼脂(HiMedia)上进行 Kirby-Bauer 纸片扩散试验进行抗生素敏感性测试。从各类临床样本中分离出289株非重复的( )。总共277株(96%)( )分离株为多重耐药菌株。( )大多从重症监护病房分离出来,并且通过本研究发现在三级医院中它是多重耐药类型最多的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b00e/9381315/9dd5dd4310f0/10-1055-s-0041-1735583-i20110312-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b00e/9381315/9dd5dd4310f0/10-1055-s-0041-1735583-i20110312-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b00e/9381315/9dd5dd4310f0/10-1055-s-0041-1735583-i20110312-1.jpg

相似文献

1
A Microbiological Study of with Special Reference to Multidrug Resistance.一项关于[具体研究对象未给出]的微生物学研究,特别提及多重耐药性。
J Lab Physicians. 2021 Sep 22;14(2):169-174. doi: 10.1055/s-0041-1735583. eCollection 2022 Jun.
2
Molecular Characterization of Class A-ESBLs, Class B-MBLs, Class C-AmpC, and Class D-OXA Carbapenemases in MDR Acinetobacter baumannii Clinical Isolates in a Tertiary Care Hospital, West Bengal, India.印度西孟加拉邦一家三级护理医院耐多药鲍曼不动杆菌临床分离株中A类超广谱β-内酰胺酶、B类金属β-内酰胺酶、C类AmpC酶和D类OXA碳青霉烯酶的分子特征分析
Cureus. 2023 Aug 17;15(8):e43656. doi: 10.7759/cureus.43656. eCollection 2023 Aug.
3
[Occurrence of alert pathogens in hospital environment Part II. Multidrug-resistant non-fermenting bacilli].[医院环境中警示病原体的出现 第二部分。多重耐药非发酵菌]
Med Dosw Mikrobiol. 2012;64(1):45-53.
4
Repeated colonization by multi-drug-resistant Acinetobacter calcoaceticus-A. baumannii complex and changes in antimicrobial susceptibilities in surgical intensive care units.多重耐药的醋酸钙不动杆菌-鲍曼不动杆菌复合体的反复定植与外科重症监护病房抗菌药物敏感性的变化。
Surg Infect (Larchmt). 2013 Feb;14(1):43-8. doi: 10.1089/sur.2012.044. Epub 2013 Feb 20.
5
[Investigation of oxacillinase genes in nosocomial multidrug-resistant Acinetobacter baumannii isolates by multiplex PCR and evaluation of their clonal relationship with Rep-PCR].[采用多重PCR法对医院内多重耐药鲍曼不动杆菌分离株中的苯唑西林酶基因进行检测并评估其与重复序列PCR的克隆关系]
Mikrobiyol Bul. 2015 Apr;49(2):249-58. doi: 10.5578/mb.8884.
6
[Antimicrobial susceptibility and molecular characterization of multidrug-resistant Acinetobacter baumannii isolated in an university hospital].[某大学医院分离的多重耐药鲍曼不动杆菌的药敏性及分子特征]
Mikrobiyol Bul. 2016 Oct;50(4):522-534. doi: 10.5578/mb.34158.
7
Efficacy of Antimicrobials Against Multidrug-Resistant from Patients in a Tertiary Care Hospital.抗微生物药物对三级医院患者的多药耐药 的疗效。
Microb Drug Resist. 2020 Jun;26(6):681-684. doi: 10.1089/mdr.2019.0004. Epub 2019 Dec 12.
8
Antimicrobial Susceptibility of Complex and Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997-2016).复杂菌株与临床分离株的抗菌药敏性:哨兵抗菌监测计划(1997 - 2016年)的结果
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S34-S46. doi: 10.1093/ofid/ofy293. eCollection 2019 Mar.
9
Antibiotic susceptibility profiles of non-fermenting gram-negative Bacilli at a Tertiary Care Hospital in Patiala, India.印度帕蒂亚拉一家三级护理医院非发酵革兰氏阴性杆菌的抗生素敏感性谱
Niger Postgrad Med J. 2017 Apr-Jun;24(2):121-125. doi: 10.4103/npmj.npmj_76_17.
10
Resistance patterns of multidrug resistant Acinetobacter baumannii in an ICU of a tertiary care hospital, Malaysia.马来西亚一家三级护理医院重症监护病房中多重耐药鲍曼不动杆菌的耐药模式
Pak J Med Sci. 2015 Nov-Dec;31(6):1383-8. doi: 10.12669/pjms.316.8445.

引用本文的文献

1
Molecular Characterization of Class A-ESBLs, Class B-MBLs, Class C-AmpC, and Class D-OXA Carbapenemases in MDR Acinetobacter baumannii Clinical Isolates in a Tertiary Care Hospital, West Bengal, India.印度西孟加拉邦一家三级护理医院耐多药鲍曼不动杆菌临床分离株中A类超广谱β-内酰胺酶、B类金属β-内酰胺酶、C类AmpC酶和D类OXA碳青霉烯酶的分子特征分析
Cureus. 2023 Aug 17;15(8):e43656. doi: 10.7759/cureus.43656. eCollection 2023 Aug.

本文引用的文献

1
High Prevalence and Endemicity of Multidrug Resistant spp. in Intensive Care Unit of a Tertiary Care Hospital, Varanasi, India.印度瓦拉纳西一家三级护理医院重症监护病房中多重耐药菌的高流行率和地方性流行情况
J Pathog. 2018 Jul 2;2018:9129083. doi: 10.1155/2018/9129083. eCollection 2018.
2
Device-Associated Healthcare-Associated Infections (DA-HAI) and the caveat of multiresistance in a multidisciplinary intensive care unit.多学科重症监护病房中的器械相关医疗保健相关感染(DA-HAI)及多重耐药问题
Med J Armed Forces India. 2017 Jul;73(3):222-231. doi: 10.1016/j.mjafi.2016.10.008. Epub 2016 Dec 16.
3
Antimicrobial resistance in hospital-acquired gram-negative bacterial infections.
医院获得性革兰氏阴性菌感染中的抗菌药物耐药性
Chest. 2015 May;147(5):1413-1421. doi: 10.1378/chest.14-2171.
4
Multidrug resistant acinetobacter.多重耐药不动杆菌
J Glob Infect Dis. 2010 Sep;2(3):291-304. doi: 10.4103/0974-777X.68538.
5
Acinetobacter baumannii: emergence of a successful pathogen.鲍曼不动杆菌:一种成功病原体的出现
Clin Microbiol Rev. 2008 Jul;21(3):538-82. doi: 10.1128/CMR.00058-07.
6
Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance.不动杆菌属所致血流感染:流行病学、危险因素及多重耐药性的影响
Eur J Clin Microbiol Infect Dis. 2008 Jul;27(7):607-12. doi: 10.1007/s10096-008-0473-y. Epub 2008 Feb 19.
7
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.医院中日益严重的威胁:多重耐药鲍曼不动杆菌。
Nat Rev Microbiol. 2007 Dec;5(12):939-51. doi: 10.1038/nrmicro1789.
8
Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates.替加环素与其他11种抗菌药物对215株经流行病学界定的多重耐药鲍曼不动杆菌分离株的体外活性比较
J Antimicrob Chemother. 2006 Nov;58(5):1099-100. doi: 10.1093/jac/dkl383. Epub 2006 Sep 14.
9
In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals.替加环素对来自希腊医院的多重耐药(包括泛耐药)革兰氏阴性和革兰氏阳性临床分离株的体外活性。
Antimicrob Agents Chemother. 2006 Sep;50(9):3166-9. doi: 10.1128/AAC.00322-06.
10
Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa.鉴定对鲍曼不动杆菌和铜绿假单胞菌感染有效的新型抗菌药物面临的挑战。
Clin Infect Dis. 2006 Sep 1;43 Suppl 2:S100-5. doi: 10.1086/504487.